BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 3, 2026
Home » Authors » Liz Hollis

Articles by Liz Hollis

Study results boost Videssa in avoiding unnecessary biopsies

Sep. 13, 2018
By Liz Hollis

Stryker buying streak continues as it agrees to acquire Invuity for $190M

Sep. 12, 2018
By Liz Hollis
Roughly two weeks after it reported its intention to buy K2m Group Holdings Inc., Kalamazoo, Mich.-based Stryker Corp. said it will acquire Invuity Inc. for $7.40 per share, or about $190 million. Invuity, of San Francisco, provides advanced photonics and single-use, lighted instruments for visualization in a variety of clinical applications, including orthopedic and spine surgery, general surgery and women's health procedures.
Read More

BioWorld MedTech's Cardiology Extra

Sep. 11, 2018
By Liz Hollis

Masimo gets FDA win with RAS-45 acoustic respiration sensor for infants, neonates

Sep. 11, 2018
By Liz Hollis
Masimo Corp. of Irvine, Calif., received FDA clearance for RAS-45, an acoustic respiration sensor for rainbow acoustic monitoring (RAM), for infant and neonatal patients. RAM previously had the green light for patients weighing more than 10 kg using RAS-125c and RAS-45 sensors.
Read More

Boston Scientific agrees to buy Augmenix for up to $600M, will get SpaceOAR system

Sep. 10, 2018
By Liz Hollis
In its largest 2018 deal to date, Boston Scientific Corp., of Marlborough, Mass., agreed to acquire Bedford, Mass.-based Augmenix Inc., which has developed the SpaceOAR system to reduce the side effects that men may experience after receiving prostate cancer radiotherapy. The deal calls for an upfront cash payment of $500 million, plus up to $100 million for reaching sales-based milestones.
Read More

Cricket Health scoops up $24M in series A

Sep. 7, 2018
By Liz Hollis
With chronic kidney disease (CKD) and end-stage renal disease (ESRD) remaining top concerns in health care, keeping patients out of the hospital is a priority. San Francisco-based Cricket Health Inc. is looking to help in this regard and now has received a boost in the form of a series A funding round of $24 million.
Read More

Vascular Dynamics initiates hypertension study

Sep. 6, 2018
By Liz Hollis
Hypertension is a ubiquitous problem that many companies – both pharma and device – are looking to address. Now, a privately held Mountain View, Calif.-based company, Vascular Dynamics Inc., is looking to offer a new minimally invasive option that can help patients who are resistant to drug therapies.
Read More

Attune Medical scoops up more than $15M in oversubscribed series C

Sep. 5, 2018
By Liz Hollis

Cybermdx helping health care facilities secure technology as old threat looms

Sep. 4, 2018
By Liz Hollis
Cybersecurity has been on the minds of health care executives for some time now. However, news that security vulnerabilities were found in Becton Dickinson and Co.'s (BD) Alaris Tiva syringe pump and the Capsule datacaptor terminal server (DTS) from Qualcomm Life Inc. has again put cybersecurity in the spotlight. That is where Cybermdx can help.
Read More

Stryker buying spine company K2m for $1.4B

Aug. 31, 2018
By Liz Hollis
As summer winds down, the M&A news keeps coming. Days after Amsterdam-based Wright Medical Group NV reported that it had agreed to acquire Cartiva Inc., a private orthopedic company in Alpharetta, Ga., for $435 million, Stryker Corp. said that it had inked a merger agreement with K2m Group Holdings Inc. Under the agreement, Stryker, of Kalamazoo, Mich., will acquire all of the issued and outstanding shares of common stock of Leesburg, Va.-based K2m in an all-cash transaction for $27.50 per share, or a total equity value of about $1.4 billion.
Read More
Previous 1 2 … 46 47 48 49 50 51 52 53 54 … 67 68 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 2, 2026.
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing